Investor Relations

Webcast

AxoGen to Report 2Q 2015 Results on August 6, 2015

Register Here

Symbol

NASDAQ: AXGN

Price

Loading...

Change

Loading...

Shares Oustanding

24932392

MKT Cap

Loading...

Volume

Loading...

AxoGen is a leading medical technology company dedicated to peripheral nerve repair. AxoGen's portfolio of regenerative medicine products is available in the United States, Canada and several other countries, and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with an additional surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.